Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127005291 | 12700529 | 1 | I | 201606 | 20160819 | 20160830 | 20160830 | EXP | US-TEVA-689161USA | TEVA | 57.13 | YR | F | Y | 69.40000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127005291 | 12700529 | 1 | PS | WARFARIN | WARFARIN | 1 | Unknown | Y | 40145 | ||||||||||
| 127005291 | 12700529 | 2 | SS | IBRANCE | PALBOCICLIB | 1 | Oral | 125 MILLIGRAM DAILY; | Y | 0 | 125 | MG | CAPSULE | QD | |||||
| 127005291 | 12700529 | 3 | SS | FEMARA | LETROZOLE | 1 | Unknown | ONCE DAILY IN MORNING | 0 | QD | |||||||||
| 127005291 | 12700529 | 4 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 0 | 10 | MG | |||||||||
| 127005291 | 12700529 | 5 | C | Oxycodone | OXYCODONE | 1 | Oral | 0 | 10 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127005291 | 12700529 | 2 | Breast cancer stage IV |
| 127005291 | 12700529 | 3 | Breast cancer stage IV |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127005291 | 12700529 | DS |
| 127005291 | 12700529 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127005291 | 12700529 | Body temperature increased | |
| 127005291 | 12700529 | Bone pain | |
| 127005291 | 12700529 | Breast cancer metastatic | |
| 127005291 | 12700529 | Breast cancer stage IV | |
| 127005291 | 12700529 | Chills | |
| 127005291 | 12700529 | Coagulopathy | |
| 127005291 | 12700529 | Fatigue | |
| 127005291 | 12700529 | Haemoglobin decreased | |
| 127005291 | 12700529 | Headache | |
| 127005291 | 12700529 | Hyperhidrosis | |
| 127005291 | 12700529 | Lung neoplasm malignant | |
| 127005291 | 12700529 | Neoplasm progression | |
| 127005291 | 12700529 | Night sweats | |
| 127005291 | 12700529 | Palpitations | |
| 127005291 | 12700529 | Pleural neoplasm | |
| 127005291 | 12700529 | Prothrombin time prolonged | |
| 127005291 | 12700529 | Pulmonary embolism | |
| 127005291 | 12700529 | Uterine leiomyoma | |
| 127005291 | 12700529 | Uterine polyp |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127005291 | 12700529 | 1 | 2013 | 0 | ||
| 127005291 | 12700529 | 2 | 201607 | 0 |